Safety of IFNa Kinoid in Systemic Lupus Erythematosus

NCT01058343 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Neovacs